Pharmacotherapeutic group: M01AC05 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic diseases, children under 14. Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg, lyophilized powder for preparation of district for injection 8 mg in vial., 8 mg vial salle . Contraindications to the use of drugs: hypersensitivity to lornoksykamu or to the drug, hypersensitivity to aspirin or other NSAIDs (ibuprofen, indomethacin), hemorrhagic diathesis or clotting disorder, stomach ulcer and duodenum in acute, ulcerative colitis, significant liver dysfunction, moderate or severe renal impairment salle creatinine> 300 mmol / l), hypovolemia or dehydration, confirmed or possible hemorrhage in the brain, BA, CH, hearing loss, lack of glucose-6-phosphate dehydrogenase, pregnancy, lactation, children age of 18, use with caution in hypertension and anemia, patients with drug diseases listed below can be used only after thorough examination of relations "benefit / risk" - bleeding from the gastrointestinal tract, ulcerative lesions in the gastrointestinal salle history; diabetes with reduced renal function.
No comments:
Post a Comment